Molecular Devices’ next-generation SpectraMax MiniMax 300 imaging cytometer is designed to enable both cellular visualization and stain-free cell-based analysis on the field-upgradable SpectraMax i3 multi-mode microplate reader. Brightfield- and fluorescence-based green and red channel cellular image acquisition and analysis is available using the SoftMax Pro software workflow. The combination of cellular imaging with stain-free cell counting and confluency measurements with microplate-based applications is designed to help scientists compress their workflows and increase efficiency.The SpectraMax MiniMax 300 imaging cytometer features the StainFree Cell Detection algorithm, which enables cell confluency and cell counting measurements on an imaging plate reader without the need for destructive stains. With two additional fluorescence detection channels-green and red–researchers may now perform and analyze a wide range of cellular viability and cell toxicity assays, including ratiometric assays such as transfection efficiency. The SpectraMax i3 system offers three integrated detection modes while its flexible design enables a wide array of assay possibilities. The patented user-exchangeable cartridge design expands the system’s detection capabilities with cartridges like the recently launched ScanLater Western blot detection system, which enables protein analysis on a plate reader.
The SpectraMax i3 platform with MiniMax 300 imaging cytometer and ScanLater western blot system are all managed through SoftMax Pro data acquisition and analysis software, recognized industry-wide for its ease of use. With simple to set-up plate reader prompts and predefined analysis features, results are realized and analyzed quickly. The SpectraMax i3 system is also available for use in GMP and GLP labs when used with SoftMax Pro 6 GxP microplate data compliance software.
Filed Under: Drug Discovery
